Failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer

We report the failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer. A 76-year-old man was admitted to our hospital for evaluation of an elevated serum prostate specific antigen (PSA) level (191.10 ng/ml...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Anticancer Drugs
Hlavní autoři: Koh, Yoko, Kawashima, Atsunari, Ujike, Takeshi, Nagahara, Akira, Fujita, Kazutoshi, Kiuchi, Hiroshi, Imamura, Ryoichi, Miyagawa, Yasushi, Nonomura, Norio, Uemura, Motohide
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams & Wilkins 2020
Témata:
Case Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7566291/
https://ncbi.nlm.nih.gov/pubmed/32804697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000986
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky